Van Diest Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Sell
4,793
-1,315
-22% -$106K 0.34% 83
2026
Q1
$529K Buy
6,108
+2,252
+58% +$216K 0.42% 65
2025
Q4
$370K Buy
+3,856
New +$375K 0.55% 55

Other funds holding MDT

Van Diest Capital's MDT Position: Q2 2026 in Review

Van Diest Capital reduced its Medtronic (MDT) stake by 22% in Q2 2026, selling an estimated $106K and leaving 4,793 shares worth $375K. The position accounts for 0.34% of the portfolio, ranked #83.

Van Diest Capital first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $529K in Q1 2026. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Van Diest Capital held 4,793 shares of Medtronic worth $375K as of Q2 2026.
  • Van Diest Capital sold 1,315 Medtronic shares in Q2 2026, an estimated $106K.
  • Medtronic made up 0.34% of Van Diest Capital's portfolio in Q2 2026, its #83 holding.
  • Van Diest Capital first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Van Diest Capital's Medtronic position peaked at $529K in Q1 2026.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.